Axsenta Pharmaceuticals Private Limited
About Axsenta Pharmaceuticals Private Limited
Data last updated:
Axsenta Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 21 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2016PTC158041. Its GSTIN is 27AAPCA8224L1Z6 (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Arun Bandu Nanavare and Shital Arun Nanaware.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 1 999 Sadashiv Peth Ambience 999, Pune, Maharashtra, India – 411030.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.25 Lakh, a decline of 89% compared to the previous year. For the same year it recorded a net loss of ₹2.53 Lakh (net margin -112.6%) and EBITDA of -₹2.52 Lakh (EBITDA margin -112.2%). Revenue has grown at a compounded annual rate (CAGR) of 86% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Axsenta Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No 1 999 Sadashiv Peth Ambience 999, Pune, Maharashtra, India – 411030
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Axsenta Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Axsenta Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Axsenta Pharmaceuticals Private Limited, buy the company report.
Financials of Axsenta Pharmaceuticals Private Limited
FY 2025 filings availableAxsenta Pharmaceuticals Private Limited reported revenue of ₹2.25 Lakh (down 89% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 89% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 86%. EBITDA fell 353% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.52 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -112.2% | ||||
| Net Profit Margin | -112.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Axsenta Pharmaceuticals Private Limited, buy the company report.
Board of directors of Axsenta Pharmaceuticals Private Limited
Axsenta Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Bandu Nanavare | Director | 26 Nov 2021 | 4 Years 11 Months | Current |
| Shital Arun Nanaware | Director | 12 Feb 2018 | 8 Years 9 Months | Current |
Auditor
Axsenta Pharmaceuticals Private Limited is audited by Venkat Narayan & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Venkat Narayan & Associates | FY 2017 | 153482 |
Shareholding
The shareholding of Axsenta Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Axsenta Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Axsenta Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Axsenta Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Axsenta Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAPCA8224L1Z6 | Maharashtra | Active | 23 Aug 2021 |
To see the full GST registrations and return filing status of Axsenta Pharmaceuticals Private Limited, buy the company report.
Recent activity
Axsenta Pharmaceuticals Private Limited has 7 board changes on record since 2016: 2 appointments and 5 cessations. The latest: Arun Bandu Nanavare was appointed as Director on 26 Nov 2021.
Frequently asked questions
Axsenta Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 21 January 2016 (10+ years old) and is registered under CIN U74999PN2016PTC158041.
Axsenta Pharmaceuticals has 2 current directors:
- Arun Bandu Nanavare - Director
- Shital Arun Nanaware - Director
The latest financial statements of Axsenta Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Axsenta Pharmaceuticals is 27AAPCA8224L1Z6, registered in Maharashtra.
The CIN (Corporate Identification Number) of Axsenta Pharmaceuticals is U74999PN2016PTC158041. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Axsenta Pharmaceuticals was incorporated on 21 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Pune.
Arun Bandu Nanavare was appointed as Director on 26 Nov 2021. Neel Arun Nanaware ceased to be Director on 26 Nov 2021. Nagesh Gurjal Madhavrao ceased to be Director on 27 May 2021. Axsenta Pharmaceuticals has 7 board changes on record in total.
The registered office of Axsenta Pharmaceuticals is at Flat No 1 999 Sadashiv Peth Ambience 999, Pune, Maharashtra, India – 411030.
Axsenta Pharmaceuticals operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Axsenta Pharmaceuticals is compliant as of 20 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
